MECP2 - methyl-CpG binding protein 2 Gene
Also Known as RS; RTS; RTT; PPMX; MRX16; MRX79; MRXSL; AUTSX3; MRXS13
Species: Homo sapiens
About MECP2
This gene has 29 transcripts (splice variants), 193 orthologues, 1 paralogue and is associated with 17 phenotypes. Ubiquitous expression in ovary (RPKM 10.4), brain (RPKM 8.2) and 25 other tissues.
Summary
DNA methylation is the major modification of eukaryotic genomes and plays an essential role in mammalian development. Human proteins MECP2, MBD1, MBD2, MBD3, and MBD4 comprise a family of nuclear proteins related by the presence in each of a methyl-CpG binding domain (MBD). Each of these proteins, with the exception of MBD3, is capable of binding specifically to methylated DNA. MECP2, MBD1 and MBD2 can also repress transcription from methylated gene promoters. In contrast to Other MBD family members, MECP2 is X-linked and subject to X inactivation. MECP2 is dispensible in stem cells, but is essential for embryonic development. MECP2 gene mutations are the cause of most cases of Rett syndrome, a progressive neurologic developmental disorder and one of the most common causes of cognitive disability in females. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Oct 2015]
MECP2 Products (10)
| mRNA | Protein | Name |
|---|---|---|
| NM_001110792.2 | NP_001104262.1 | methyl-CpG-binding protein 2 isoform 2 |
| NM_001316337.2 | NP_001303266.1 | methyl-CpG-binding protein 2 isoform 3 |
| NM_001369391.2 | NP_001356320.1 | methyl-CpG-binding protein 2 isoform 3 |
| NM_001369392.2 | NP_001356321.1 | methyl-CpG-binding protein 2 isoform 3 |
| NM_001369393.2 | NP_001356322.1 | methyl-CpG-binding protein 2 isoform 3 |
| NM_001369394.2 | NP_001356323.1 | methyl-CpG-binding protein 2 isoform 3 |
| NM_001386137.1 | NP_001373066.1 | methyl-CpG-binding protein 2 isoform 4 |
| NM_001386138.1 | NP_001373067.1 | methyl-CpG-binding protein 2 isoform 4 |
| NM_001386139.1 | NP_001373068.1 | methyl-CpG-binding protein 2 isoform 4 |
| NM_004992.4 | NP_004983.1 | methyl-CpG-binding protein 2 isoform 1 |
| Molecular Function GO Annotation | Evidence | References | Source |
|---|---|---|---|
| enables double-stranded methylated DNA binding |
IMP
IMP: Inferred from mutant phenotype
|
17296936 | GOA |
| enables molecular adaptor activity |
EXP
EXP: Inferred from Experiment
|
20405910 | GOA |
| enables molecular condensate scaffold activity |
IMP
IMP: Inferred from mutant phenotype
|
32698189 | GOA |
| enables nucleic acid binding |
EXP
EXP: Inferred from Experiment
|
20405910 | GOA |
| enables protein binding |
IPI
IPI: Inferred from physical interaction
|
11441023 | GOA |
| enables transcription corepressor activity |
IDA
IDA: Inferred from direct assay
|
10773092 | GOA |
| Biological Process GO Annotation | Evidence | References | Source |
|---|---|---|---|
| acts upstream of or within genomic imprinting |
IMP
IMP: Inferred from mutant phenotype
|
15608638 | GOA |
| involved in negative regulation of DNA-templated transcription |
IDA
IDA: Inferred from direct assay
|
11441023 | GOA |
| involved in negative regulation of angiogenesis |
IMP
IMP: Inferred from mutant phenotype
|
23960241 | GOA |
| involved in negative regulation of blood vessel endothelial cell migration |
IDA
IDA: Inferred from direct assay
|
23960241 | GOA |
| involved in negative regulation of gene expression |
IDA
IDA: Inferred from direct assay
|
23960241 | GOA |
| involved in negative regulation of gene expression via chromosomal CpG island methylation |
IDA
IDA: Inferred from direct assay
|
23960241 | GOA |
| involved in positive regulation of microtubule nucleation |
IMP
IMP: Inferred from mutant phenotype
|
25527496 | GOA |
| Cellular Component GO Annotation | Evidence | References | Source |
|---|---|---|---|
| located in centrosome |
IMP
IMP: Inferred from mutant phenotype
|
25527496 | GOA |
| located in heterochromatin |
IDA
IDA: Inferred from direct assay
|
11441023 | GOA |
| located in nucleus |
IDA
IDA: Inferred from direct assay
|
11441023 | GOA |
MECP2 Protein Structure
MBD: Methyl-CpG binding domain (93 - 160)
- 0
- 100
- 200
- 300
- 400
- 486 a.a.
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
methyl-CpG-binding protein 2 |
|
MECP2 Protein-protein interaction Information
|
Type
|
Protein Name | Protein ID | Interactor | Interactor Species | Interactor ID | Detection Method | References |
|---|---|---|---|---|---|---|---|
|
Cross
|
MECP2 | P51608 | Tbl1xr1 | Mus musculus | Q8BHJ5 | 23770565 | |
|
Cross
|
MECP2 | P51608 | Tbl1xr1 | Mus musculus | Q8BHJ5 | 23770565 | |
|
Intra
|
MECP2 | P51608 | SIN3A | Homo sapiens | Q96ST3 | 23770565 | |
|
Intra
|
MECP2 | P51608 | HIPK2 | Homo sapiens | Q9H2X6 | 19820693 | |
|
Cross
|
MECP2 | P51608 | Ncor1 | Mus musculus | Q60974 | 23770565 | |
|
Cross
|
MECP2 | P51608 | Ncor1 | Mus musculus | Q60974 | 23770565 | |
|
Intra
|
MECP2 | P51608 | HSPB1 | Homo sapiens | P04792 | 32814053 | |
|
Intra
|
MECP2 | P51608 | HSPB1 | Homo sapiens | P04792 | 32814053 | |
|
Intra
|
MECP2 | P51608 | HSPB1 | Homo sapiens | P04792 | 32814053 | |
|
Cross
|
MECP2 | P51608 | Hipk2 | Mus musculus | Q9QZR5 | 19820693 | |
|
Cross
|
MECP2 | P51608 | Hipk2 | Mus musculus | Q9QZR5 | 19820693 | |
|
Intra
|
MECP2 | P51608 | NEFL | Homo sapiens | P07196 | 32814053 | |
|
Intra
|
MECP2 | P51608 | NEFL | Homo sapiens | P07196 | 32814053 | |
|
Intra
|
MECP2 | P51608 | NEFL | Homo sapiens | P07196 | 32814053 | |
|
Cross
|
MECP2 | P51608 | Ncor2 | Mus musculus | Q9WU42 | 23770565 | |
|
Cross
|
MECP2 | P51608 | Ncor2 | Mus musculus | Q9WU42 | 23770565 | |
|
Intra
|
MECP2 | P51608 | SMARCA2 | Homo sapiens | P51531 | 15696166 | |
|
Intra
|
MECP2 | P51608 | KLHL20 | Homo sapiens | Q9Y2M5 | 33961781 | |
|
Intra
|
MECP2 | P51608 | WFS1 | Homo sapiens | O76024 | 32814053 | |
|
Intra
|
MECP2 | P51608 | WFS1 | Homo sapiens | O76024 | 32814053 | |
|
Intra
|
MECP2 | P51608 | WFS1 | Homo sapiens | O76024 | 32814053 | |
|
Intra
|
MECP2 | P51608 | PRPS1 | Homo sapiens | P60891 | 32814053 | |
|
Intra
|
MECP2 | P51608 | PRPS1 | Homo sapiens | P60891 | 32814053 | |
|
Intra
|
MECP2 | P51608 | PRPS1 | Homo sapiens | P60891 | 32814053 | |
|
Intra
|
MECP2 | P51608 | MAX | Homo sapiens | P61244 | 25609649 | |
|
Intra
|
MECP2 | P51608 | SUMO1 | Homo sapiens | P63165 | 37261502 | |
|
Cross
|
MECP2 | P51608 | Tbl1x | Mus musculus | Q9QXE7 | 23770565 | |
|
Cross
|
MECP2 | P51608 | Tbl1x | Mus musculus | Q9QXE7 | 23770565 |
Recombinant MECP2 Proteins
| Cat. No. | Product Name | Accession | Purity |
|---|---|---|---|
| HY-P70366 | MeCP2 Protein, Human (HEK293, His) | P51608-1 (M1-S486) | ≥ 90%, as determined by reducing SDS-PAGE. |
MECP2 Antibodies
| Cat. No. | Product Name | Application | Reactivity |
|---|---|---|---|
| HY-P84372 | MECP2 Antibody (YA4069) | WB, IHC-P, ICC/IF, FC, ELISA | Human |
| HY-P84372A | MECP2 Antibody (YA4069)(PBS only) | WB, IHC-P, ICC/IF, FC, ELISA | Human |
| HY-P86190 | MECP2 Antibody (YA5882) | WB, IHC-P, ICC/IF, IP, ELISA | Human, Mouse, Rat |
Related Diseases
| Diseases | Alias | |
|---|---|---|
| Rett Syndrome |
|
|
| Encephalopathy, Neonatal Severe, Due To Mecp2 Mutations |
|
|
| Intellectual Developmental Disorder, X-Linked, Syndromic 13 |
|
|
| Autism X-Linked 3 |
|
|
| Intellectual Developmental Disorder, X-Linked, Syndromic, Lubs Type |
|
|
| X-Linked Intellectual Disability-Psychosis-Macroorchidism Syndrome |
|
|
| Non-Syndromic X-Linked Intellectual Disability |
|
|
| Syndromic X-Linked Intellectual Disability Lubs Type |
|
|
| Bruxism |
|
|
| Stereotypic Movement Disorder |
|
|
| Angelman Syndrome |
|
|
| Attention Deficit-Hyperactivity Disorder |
|
|
| Motor Stereotypies |
|
|
| Nervous System Disease |
|
|
| Congenital Nervous System Abnormality |
|
|
| Pervasive Developmental Disorder |
|
|
| Facial Hypertrichosis |
|
|
| Laryngomalacia |
|
|
| Learning Disability |
|
|
| Sick Sinus Syndrome |
|
|
| Focal Epilepsy |
|
|
| Fragile X Syndrome |
|
|
| Epilepsy |
|
|
| Gene Duplication Disease |
|
|
| Dystonia |
|
|
| Gait Apraxia |
|
|
| Childhood Disintegrative Disease |
|
|
| Microcephaly |
|
|
| Asperger Syndrome |
|
|
| Immunodeficiency-Centromeric Instability-Facial Anomalies Syndrome |
|
|
| Autism |
|
|
| Kbg Syndrome |
|
|
| Speech And Communication Disorders |
|
|
| Encephalopathy |
|
|
| Spasticity |
|
|
| West Syndrome |
|
|
| Hypertelorism |
|
|
| Echolalia |
|
|
| Systemic Lupus Erythematosus |
|
|
| Neurodegeneration With Brain Iron Accumulation |
|
|
| Meningoencephalitis |
|
|
| Hypogonadotropic Hypogonadism |
|
|
| Alcohol-Related Neurodevelopmental Disorder |
|
|
| Gastroesophageal Reflux |
|
|
| Specific Developmental Disorder |
|
|
| Down Syndrome |
|
|
| Alpha Thalassemia-X-Linked Intellectual Disability Syndrome |
|
|
| Hypotonia |
|
|
| Pitt-Hopkins Syndrome |
|
|
| Pitt-Hopkins-Like Syndrome 1 |
|
|
| Scoliosis |
|
|
| Atypical Autism |
|
|
| Chromosome 16p13.3 Deletion Syndrome, Proximal |
|
|
| Fetal Alcohol Spectrum Disorder |
|
|
| Kleefstra Syndrome |
|
|
| Developmental And Epileptic Encephalopathy 17 |
|
|
| Autism Spectrum Disorder |
|
|
| Coffin-Siris Syndrome 1 |
|
|
| Prader-Willi Syndrome |
|
|
| Christianson Syndrome |
|
|
| Disease Of Mental Health |
|
|
| X-Linked Intellectual Disability-Cardiomegaly-Congestive Heart Failure Syndrome |
|
|
| Partington Syndrome |
|
|
| Phelan-Mcdermid Syndrome |
|
|
| Chromosomal Duplication Syndrome |
|
|
| Mowat-Wilson Syndrome |
|
|
| Otopalatodigital Syndrome, Type I |
|
|
| Sudden Infant Death Syndrome |
|
|
| Coffin-Lowry Syndrome |
|
|
| Nescav Syndrome |
|
|
| Anxiety |
|
|
| Timothy Syndrome |
|
|
| Potocki-Lupski Syndrome |
|
|
| Developmental And Epileptic Encephalopathy 47 |
|
|
| Cerebellar Ataxia, Deafness, And Narcolepsy, Autosomal Dominant |
|
|
| Chromosomal Disease |
|
|
| Bone Structure Disease |
|
|
| Syndromic X-Linked Intellectual Disability |
|
|
| Valproate Embryopathy |
|
|
| Chromosomal Deletion Syndrome |
|
|
| Pelizaeus-Merzbacher Disease |
|
|
| Developmental And Epileptic Encephalopathy 2 |
|
|
| Fetal Alcohol Syndrome |
|
|
| Cowden Syndrome 1 |
|
|
| Hyperoxaluria, Primary, Type I |
|
|
| Peho Syndrome |
|
|
| Schizophrenia |
|
|
| Syndromic Intellectual Disability |
|
|
| Sotos Syndrome |
|
|
| Primary Hyperoxaluria |
|
|
| Kleefstra Syndrome 1 |
|
|
| Alpha-Thalassemia |
|
|
| Opitz-Kaveggia Syndrome |
|
|
| Atrial Septal Defect 8 |
|
|
| Dravet Syndrome |
|
|
| Megalencephalic Leukoencephalopathy With Subcortical Cysts 2a |
|
|
| Intellectual Developmental Disorder, Autosomal Dominant 30, With Speech Delay And Behavioral Abnormalities |
|
|
| Myopathy |
|
|
| Noonan Syndrome 1 |
|
|
| Lennox-Gastaut Syndrome |
|
|
| Early Myoclonic Encephalopathy |
|
|
| Developmental And Epileptic Encephalopathy 14 |
|
|
| Syndromic X-Linked Intellectual Disability Type 10 |
|
|
| Psychotic Disorder |
|
|
| Hypomyelinating Leukodystrophy |
|
|
| Speech Disorder |
|
|
| Congenital Central Hypoventilation Syndrome |
|
|
| Velocardiofacial Syndrome |
|
|
| Cornelia De Lange Syndrome |
|
|
| Early Infantile Epileptic Encephalopathy |
|
|
| Developmental And Epileptic Encephalopathy |
|
|
| Williams-Beuren Syndrome |
|
|
| Childhood Absence Epilepsy |
|
|
| Chromosome 1p36 Deletion Syndrome |
|
|
| Rasopathy |
|
|
| Beckwith-Wiedemann Syndrome |
|
|
| Chromosome 22q11.2 Deletion Syndrome, Distal |
|
|
| Strabismus |
|
|
| Benign Epilepsy With Centrotemporal Spikes |
|
|
| Hirschsprung Disease 1 |
|
|
| Amyotrophic Lateral Sclerosis 1 |
|
|
| Retinitis Pigmentosa |
|
|
Orthologs Information
| Species | Symbol | Source | ID |
|---|---|---|---|
| Felis catus | MECP2 | VGNC | VGNC:68228 |
| Mus musculus | MECP2 | MGD | MGI:99918 |
| Bos taurus | MECP2 | VGNC | VGNC:31344 |
| Macaca mulatta | MECP2 | VGNC | VGNC:74697 |
| Canis familiaris | MECP2 | VGNC | VGNC:43115 |
| Rattus norvegicus | MECP2 | RGD | RGD:3075 |
| Others | MECP2 | NCBI |